Testosterone in women: Can the challenges be met?

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 8, 2015, Pages 588-590

  Davis, Susan R ^a   Parish, Sharon J ^b  

^a MONASH UNIVERSITY   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PHOSPHODIESTERASE V INHIBITOR; TESTOSTERONE;

ANDROGEN THERAPY; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MASTURBATION; NOTE; ORGASM; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL SATISFACTION; TESTOSTERONE BLOOD LEVEL; TRANSDERMAL PATCH; UNSPECIFIED SIDE EFFECT; DRUG EFFECTS; MALE; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TRENDS; WOMEN'S HEALTH;

FEMALE; HUMANS; MALE; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; WOMEN'S HEALTH;

EID: 84938213500     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00207-7     Document Type: Note

References (15)

1. Snabes MC, Simes SM Approved Hormonal Treatments for HSDD: an unmet medical need. J Sex Med 2009, 6:1846-1849.
2. Wåhlin-Jacobsen S, Pedersen AT, Kristensen E, et al. Is there a correlation between androgens and sexual desire in women?. J Sex Med 2014, 12:358-373.
3. Randolph JF, Zheng H, Avis NE, Greendale GA, Harlow SD Masturbation frequency and sexual function domains are associated with serum reproductive hormone levels across the menopausal transition. J Clin Endocrinol Metab 2015, 100:258-266.
4. Somboonporn W, Davis S, Seif M, Bell R Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005, 4. CD004509 (updated 2009).
5. Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014, 99:3489-3510.
6. Spark RF Intrinsa Fails to impress FDA advisory panel. Int J Impot Res 2005, 17:283-284.
7. Panay N, Al-Azzawi F, Bouchard C, et al. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric 2010, 13:121-131.
8. Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in menopausal women not taking estrogen therapy. N Eng J Med 2008, 359:2005-2017.
9. Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR The relationship between self-reported sexual satisfaction and general well-being in women. J Sex Med 2009, 6:2690-2697.
10. Araujo AB, Mohr BA, McKinlay JB Changes in sexual function in middle-aged and older men: longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 2004, 52:1502-1509.
11. Padma-Nathan H, Steers WD, Wicker PA Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Sildenafil Study Group. Int J Clin Pract 1998, 52:375-379.
12. White WB, Grady D, Giudice LC, et al. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. Am Heart J 2012, 163:27-32.
13. Lee DM, Nazroo J, O'Connor DB, Blake M, Pendleton N sexual health and well-being among older men and women in England: findings from the English Longitudinal Study of Ageing. Arch Sex Behav 2015, published online Jan 27. 10.1007/s10508-014-0465-1.
14. Fooladi E, Bell RJ, Whittaker AM, Davis SR Women's expectations and experiences of hormone treatment for sexual dysfunction. Climacteric 2014, 17:1-20.
15. Lakshman KM, Basaria S Safety and efficacy of testosterone gel in the treatment of male hypogonadism. Clin Interv Aging 2009, 4:397-412.